Adaptilens Announces $17.5M Series a Financing
Perceptive Xontogeny Venture Funds Leads Financing to Support Development of Accommodating Intraocular Lens (A-IOL) Through First-in-Human Trials, Paving the Way to Transform Cataract Surgery's Standard of Care BOSTON, April 29, 2024 /PRNewswire…